Publications - Released in 2016
This annual accounting of funding for biomedical HIV prevention research tracks trends and identifies gaps in investment. In 2015, reported funding for HIV prevention R&D decreased from US$ 1.25 billion in 2014 to US$1.20 billion. However, overall funding has remained essentially flat for over a decade. While investments towards research for preventive vaccines and female condoms increased from 2014 levels, investments towards microbicides, PrEP, TasP, VMMC and PMTCT declined.
Downloads
Organizations
- HIV Resource Tracking
- AIDS Vaccine Advocacy Coalition (AVAC)
- International AIDS Vaccine Initiative (IAVI)
- United States President′s Emergency Plan for AIDS Relief (PEPFAR)
- United States Agency for International Development (USAID)
- Bill and Melinda Gates Foundation